The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice

被引:34
作者
Plowman, SJ
Arends, MJ
Brownstein, DG
Luo, FJ
Devenney, PS
Rose, L
Ritchie, AM
Berry, RL
Harrison, DJ
Hooper, ML
Patek, CE
机构
[1] Univ Edinburgh, Sir Alastair Currie Canc Res UK Labs, Mol Med Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England
[3] Univ Edinburgh, Queens Med Res Inst, Res Anim Pathol Core Lab, Edinburgh EH16 4TJ, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
alternative splicing; apoptosis; differentiation; intestine; isoform; proliferation; K-ras; stem cell;
D O I
10.1016/j.yexcr.2005.10.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ras proteins function as molecular switches in signal transduction pathways, and, here, we examined the effects of the K-ras4A and 413 splice variants on cell function by comparing wild-type embryonic stem (ES) cells with K-ras(tm Delta 4A/tm Delta 4A) (exon 4A knock-out) ES cells which express K-ras4B only and K-ras(-/-) (exons 1 - 3 knock-out) ES cells which express neither splice variant, and intestinal epithelium from wild-type and K-ras(tm Delta 4A/tm Delta 4A) mice. RT-qPCR analysis found that K-ras4B expression was reduced in K-ras(tm Delta 4A/tm Delta 4A) ES cells but unaffected in small intestine. K-Ras deficiency did not affect ES cell growth, and K-Ras4A deficiency did not affect intestinal epithelial proliferation. K-ras(tm Delta 4A/tm Delta 4A) and K-ras(-/-) ES cells showed a reduced capacity for differentiation following LIF withdrawal, and K-ras(-/-) cells were least differentiated. K-Ras4A deficiency inhibited etoposide-induced apoptosis in ES cells and intestinal epithelial cells. However, K-ras(tm Delta 4A/tm Delta 4A) ES cells were more resistant to etoposide-induced apoptosis than K-ras(-/-) cells. The results indicate that (1) K-Ras4A promotes apoptosis while K-Ras4B inhibits it, and (2) K-Ras4B, and possibly K-Ras4A, promotes differentiation. The findings raise the possibility that alteration of the K-Ras4A4B isoform ratio modulates tumorigenesis by differentially affecting stem cell survival and/or differentiation. However, K-Ras4A deficiency did not affect life expectancy or spontaneous overall tumor incidence in aging mice. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:16 / 26
页数:11
相关论文
共 47 条
[1]   Blocking oncogenic Ras signaling for cancer therapy [J].
Adjei, AA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14) :1062-1074
[2]   Therapeutic implications of cancer stem cells [J].
Al-Hajj, M ;
Becker, MW ;
Wichal, M ;
Weissman, I ;
Clarke, MF .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (01) :43-47
[3]  
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[4]   Splice variants as cancer biomarkers [J].
Brinkman, BMN .
CLINICAL BIOCHEMISTRY, 2004, 37 (07) :584-594
[5]   Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19ARF [J].
Brooks, DG ;
James, RM ;
Patek, CE ;
Williamson, J ;
Arends, MJ .
ONCOGENE, 2001, 20 (17) :2144-2152
[6]   Signalling, cell cycle and pluripotency in embryonic stem cells [J].
Burdon, T ;
Smith, A ;
Savatier, P .
TRENDS IN CELL BIOLOGY, 2002, 12 (09) :432-438
[7]   Detecting changes in the relative expression of KRAS2 splice variants using polymerase colonies [J].
Butz, JA ;
Roberts, KG ;
Edwards, JS .
BIOTECHNOLOGY PROGRESS, 2004, 20 (06) :1836-1839
[8]   ACTIVATION OF KI-RAS 2 GENE IN HUMAN-COLON AND LUNG CARCINOMAS BY 2 DIFFERENT POINT MUTATIONS [J].
CAPON, DJ ;
SEEBURG, PH ;
MCGRATH, JP ;
HAYFLICK, JS ;
EDMAN, U ;
LEVINSON, AD ;
GOEDDEL, DV .
NATURE, 1983, 304 (5926) :507-513
[9]  
Cheng L, 2003, WORLD J GASTROENTERO, V9, P2642
[10]   Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways [J].
Choi, JA ;
Park, MT ;
Kang, CM ;
Um, HD ;
Bae, S ;
Lee, KH ;
Kim, TH ;
Kim, JH ;
Cho, CK ;
Lee, YS ;
Chung, HY ;
Lee, SJ .
ONCOGENE, 2004, 23 (01) :9-20